KNTC1 showed good sensitivity and specificity and could be better used as a prognostic factor for patients with cervical cancer (Figure 1g); however, results also suggested that there was no statistically significant difference in survival time distribution between the groups (Figure 1h). This evidence concerns the gene KNTC1 and cervical carcinoma.